Next Article in Journal
Target Analysis and Retrospective Screening of Multiple Mycotoxins in Pet Food Using UHPLC-Q-Orbitrap HRMS
Next Article in Special Issue
Development of an UPLC-MS/MS Method for the Analysis of Mycotoxins in Rumen Fluid with and without Maize Silage Emphasizes the Importance of Using Matrix-Matched Calibration
Previous Article in Journal
Accumulation of Microcystin-LR in Grains of Two Rice Varieties (Oryza sativa L.) and a Leafy Vegetable, Ipomoea aquatica
Previous Article in Special Issue
Occurrence of Mycotoxins in Swine Feeding from Spain
Open AccessArticle

Characterization of Phase I and Glucuronide Phase II Metabolites of 17 Mycotoxins Using Liquid Chromatography—High-Resolution Mass Spectrometry

1
Department of Chemistry and Biochemistry, Concordia University, 7141 Sherbrooke Street West, Montreal, QC H4B 1R6, Canada
2
Centre for Biological Applications of Mass Spectrometry, Concordia University, 7141 Sherbrooke Street West, Montreal, QC H4B 1R6, Canada
*
Author to whom correspondence should be addressed.
Toxins 2019, 11(8), 433; https://doi.org/10.3390/toxins11080433
Received: 15 June 2019 / Revised: 18 July 2019 / Accepted: 19 July 2019 / Published: 24 July 2019
(This article belongs to the Special Issue Application of LC-MS/MS in the Mycotoxins Studies)
Routine mycotoxin biomonitoring methods do not include many mycotoxin phase I and phase II metabolites, which may significantly underestimate mycotoxin exposure especially for heavily metabolized mycotoxins. Additional research efforts are also needed to measure metabolites in vivo after exposure and to establish which mycotoxin metabolites should be prioritized for the inclusion during large-scale biomonitoring efforts. The objective of this study was to perform human in vitro microsomal incubations of 17 mycotoxins and systematically characterize all resulting metabolites using liquid chromatography–high-resolution mass spectrometry (LC-HRMS). The results obtained were then used to build a comprehensive LC-MS library and expand a validated 17-mycotoxin method for exposure monitoring to screening of additional 188 metabolites, including 100 metabolites reported for the first time. The final method represents one of the most comprehensive LC-HRMS methods for mycotoxin biomonitoring or metabolism/fate studies. View Full-Text
Keywords: mycotoxins; metabolism; high-resolution mass spectrometry (HRMS); microsomal incubation; glucuronidation; human; biomonitoring mycotoxins; metabolism; high-resolution mass spectrometry (HRMS); microsomal incubation; glucuronidation; human; biomonitoring
Show Figures

Graphical abstract

MDPI and ACS Style

Slobodchikova, I.; Sivakumar, R.; Rahman, M.S.; Vuckovic, D. Characterization of Phase I and Glucuronide Phase II Metabolites of 17 Mycotoxins Using Liquid Chromatography—High-Resolution Mass Spectrometry. Toxins 2019, 11, 433.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop